Side Effects of Sustained-Release Vaginal Suppository Progesterone in Pregnant Women: Gestational Diabetes Mellitus

Neda  Kheyri; Maryam  Anbarlooi; soraya saleh gargari; Fatemeh Sadat  Sarfjoo

Annals of Military and Health Sciences Research

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors and Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support

Authors Guide Submit Manuscript

Side Effects of Sustained-Release Vaginal Suppository Progesterone in Pregnant Women: Gestational Diabetes Mellitus

Author(s):

Neda Kheyri¹,

Maryam Anbarlooi¹,

soraya saleh gargari^2,*,

Fatemeh Sadat Sarfjoo³

1Researcher, Department of obstetrics and gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Andorra

2Department of obstetrics and gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Andorra

3- Researcher, Department of obstetrics and gynecology, Mahdiyeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Andorra

Annals of Military and Health Sciences Research:Vol. 11, issue 4; e64614

Published online:Dec 02, 2013

Article type:Research Article

Received:Aug 24, 2013

Accepted:Nov 17, 2013

How to Cite:Neda Kheyri Maryam Anbarlooisoraya saleh gargari Fatemeh Sadat SarfjooSide Effects of Sustained-Release Vaginal Suppository Progesterone in Pregnant Women: Gestational Diabetes Mellitus.Ann Mil Health Sci Res.11(4):e64614.

Abstract

Background: Evaluation of the potential impact of vaginal progesterone on both mother and fetus is necessary before expanding the indication of this drug especially throughout pregnancy. To evaluate the potential impact of vaginal progesterone on both mother and fetus. Materials and Methods: This case-control study was designed to collect data on the potential gestational diabetes mellitus complication associated with progesterone use comparing maternal and neonatal outcomes between 245pregnant women receiving vaginal suppository of Cyclogest (200mg) and 808controls without progesterone. Results: The incidence of gestational diabetes was 9.8% and 5.2% in case and control groups, respectively (p=0.039). According to linear regression analysis, there was a direct association between duration of progesterone usage and impairment of glucose tolerance test in group of cases (r=0.43; p=0.002). Conclusions: The use of progesterone for the prevention of recurrent preterm delivery could associate with an increased risk of developing gestational diabetes.

Keywords

Fulltext

full text is available in pdf.

References

1.
References are available in pdf.

comments